Mrs Kerry Towers - Inquiry Concluded

04 March 2026
Logo

Harness Racing New South Wales (HRNSW) Stewards concluded an Inquiry today that commenced on 16 April 2025 into a report received from the Australian Racing Forensic Laboratory (ARFL) that Deferoxamine was detected in the post-race urine sample taken from EXPLOSIVE BRONSKI following its win in Race 3, TIGER TARA @ MEDOWIE LODGE PACE (1609 metres) conducted at Tabcorp Park Menangle on Tuesday 16 January 2024.

Deferoxamine was not detected by Racing Analytical Services Limited in Victoria in the reserve portion or the control solution.

On 16 April 2025, Dr Wainscott provided evidence that it was his belief that this detection of deferoxamine by the ARFL was the first of its kind in the world. Also on that date, evidence was presented to the Inquiry that dirt from the horse’s sheath had fallen into the urine sample.

Consequently, the Inquiry was adjourned on that date to allow HRNSW Stewards to conduct further investigation, including further analysis of the remaining samples in an attempt to determine the source of the deferoxamine after environmental contamination was identified as a possibility.

Mrs Towers appeared at the resumption of the Inquiry today.

HRNSW Regulatory Veterinarian Dr Martin Wainscott presented further evidence to the Inquiry, including investigations conducted by ARFL that confirmed bacterial activity in the ‘A’ portion of the urine sample.

In addition, Dr Wainscott presented a report from Professor Greg Challis in which he provided his professional opinion that “the finding of desferrioxamine B in one of the two samples most likely resulted from contamination with a bacterium able to produce this widely distributed iron sequestering metabolite”.

Following consideration of the totality of the evidence, HRNSW Stewards could not be comfortably satisfied that the substance Deferoxamine was in the horse’s system at the time it was presented to race and were satisfied the Deferoxamine was subsequently produced as a result of bacterial contamination after the collection of the urine sample.

Consequently, HRNSW Stewards took no action against Mrs Towers.

In addition, as Stewards found that the horse was not presented to race with a prohibited substance in its system, no action was taken against the horse and the original placings for the subject race would remain.

FOR FURTHER INFORMATION PLEASE CONTACT:

 

Name:

 

Michael Prentice                           Clint Bentley

Position:

Chief Integrity Officer                      Chairman of Stewards

Phone:

(02) 9722 6600                               (02) 9722 6628

Email:

mprentice@hrnsw.com.au              cbentley@hrnsw.com.au 

 

Related News

30 April 2026
Cobalt Samples Analysed Since 01 August 2024
DATE HORSE TRAINER COBALT ug/L URINE SAMPLES 1/08/2024 RICKOSHAY B Fitzpatrick <5 2/08/2024 KIALLA KID D Farrar <5 2/08/2024 SIGNIFICANT LAZ R Woodhouse <5 2/08/2024 CARBAGANOOSH D Dwyer <5 3/08/2024 JOETOMO A O'Connor <5 6/08/2024 DOWN UNDER EARL T Williams <5 6/08/2024 DESTINY...
9 April 2026
Industry Notice – Melton Temporary Push Out Position
Industry Notice – Melton Temporary Push Out Position Following a proposal and lengthy consultation with representatives from the Victorian Trainers & Drivers Association (VTDA), Stewards advise that the Push Out Position at Melton will be temporarily relocated under a controlled trial. This...
9 April 2026
Ms Shannon Price - Inquiry Conducted
On Wednesday 1 April 2026, Harness Racing New South Wales (HRNSW) Stewards conducted an Inquiry into a report received from the Australian Racing Forensic Laboratory (ARFL) that tiludronic acid was detected in an Out of Competition blood sample obtained from the horse SURE THING CAPTAIN on Thursday 4...
Click for more